600276.SS Stock Analysis
60
Uncovered
Jiangsu Hengrui Pharmaceuticals Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. The company is headquartered in Lianyungang, Jiangsu and currently employs 24,491 full-time employees. The company went IPO on 2000-10-18. The firm's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The firm distributes its products within domestic market and to overseas markets.